ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $399,000 | -80.3% | 97,509 | -82.8% | 0.00% | – |
Q4 2021 | $2,022,000 | +235.9% | 566,664 | +242.5% | 0.00% | – |
Q3 2021 | $602,000 | +527.1% | 165,469 | +661.4% | 0.00% | – |
Q2 2021 | $96,000 | -87.6% | 21,731 | -88.4% | 0.00% | – |
Q1 2021 | $772,000 | +207.6% | 187,937 | +199.0% | 0.00% | – |
Q4 2020 | $251,000 | +9.1% | 62,859 | -26.2% | 0.00% | – |
Q3 2020 | $230,000 | -16.4% | 85,220 | -15.0% | 0.00% | – |
Q2 2020 | $275,000 | +83.3% | 100,214 | +57.8% | 0.00% | – |
Q1 2020 | $150,000 | -83.3% | 63,507 | -66.7% | 0.00% | – |
Q4 2019 | $897,000 | +167.8% | 190,986 | +90.7% | 0.00% | – |
Q3 2019 | $335,000 | -18.1% | 100,156 | -19.4% | 0.00% | – |
Q2 2019 | $409,000 | +25.8% | 124,271 | +16.0% | 0.00% | – |
Q1 2019 | $325,000 | +261.1% | 107,134 | +223.0% | 0.00% | – |
Q4 2018 | $90,000 | -69.9% | 33,164 | -62.7% | 0.00% | – |
Q3 2018 | $299,000 | +273.8% | 88,938 | +190.9% | 0.00% | – |
Q2 2018 | $80,000 | -26.6% | 30,572 | -38.8% | 0.00% | – |
Q1 2018 | $109,000 | +17.2% | 49,975 | +6.9% | 0.00% | – |
Q4 2017 | $93,000 | -79.0% | 46,751 | -65.7% | 0.00% | – |
Q3 2017 | $442,000 | +351.0% | 136,338 | +344.2% | 0.00% | – |
Q2 2017 | $98,000 | +19.5% | 30,694 | +7.1% | 0.00% | – |
Q1 2017 | $82,000 | +256.5% | 28,664 | +192.5% | 0.00% | – |
Q4 2016 | $23,000 | +21.1% | 9,800 | -45.9% | 0.00% | – |
Q2 2016 | $19,000 | +1800.0% | 18,125 | +2140.4% | 0.00% | – |
Q3 2015 | $1,000 | -83.3% | 809 | -72.8% | 0.00% | – |
Q2 2015 | $6,000 | -91.3% | 2,971 | -91.3% | 0.00% | – |
Q1 2015 | $69,000 | +430.8% | 34,309 | +416.0% | 0.00% | – |
Q4 2014 | $13,000 | +225.0% | 6,649 | +64.5% | 0.00% | – |
Q3 2014 | $4,000 | 0.0% | 4,041 | +94.1% | 0.00% | – |
Q2 2014 | $4,000 | -71.4% | 2,082 | -54.8% | 0.00% | – |
Q1 2014 | $14,000 | -44.0% | 4,609 | -26.7% | 0.00% | – |
Q4 2013 | $25,000 | +47.1% | 6,286 | +48.8% | 0.00% | – |
Q3 2013 | $17,000 | -29.2% | 4,225 | -27.5% | 0.00% | – |
Q2 2013 | $24,000 | – | 5,831 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
EAM Investors, LLC | 251,619 | $810,000 | 0.13% |